Bristol Myers Squibb (BMY) Research & Development (2009 - 2026)
Bristol Myers Squibb (BMY) reported Research & Development of $2.6 billion for Q1 2026, up 17.37% year-over-year from $2.3 billion in Q1 2025, and up 2.44% on a QoQ basis from $2.6 billion in Q4 2025.
Bristol Myers Squibb (BMY) has 18 years of Research & Development data on file, last reported at $2.6 billion in Q1 2026.
- Quarterly Research & Development rose 17.37% year-over-year to $2.6 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $10.3 billion (down 3.53% YoY) and the FY2025 annual result came in at $10.0 billion, down 10.83% from the prior year.
- Research & Development climbed to $2.6 billion in Q1 2026 per BMY's latest filing, from $2.6 billion in the prior quarter.
- Across five years, Research & Development topped out at $3.2 billion in Q4 2024 and bottomed at $2.2 billion in Q3 2023.
- The 5-year median for Research & Development is $2.5 billion (2023), against an average of $2.5 billion.
- The widest annual swing landed in 2024, when Research & Development rose 28.77%; it then declined 18.96% in 2025.
- Tracing BMY's Research & Development over 5 years: stood at $2.5 billion in 2022, then decreased by 1.27% to $2.5 billion in 2023, then climbed by 28.77% to $3.2 billion in 2024, then decreased by 18.96% to $2.6 billion in 2025, then grew by 2.44% to $2.6 billion in 2026.
- Per Business Quant, the three latest BMY Research & Development figures stand at $2.6 billion (Q1 2026), $2.6 billion (Q4 2025), and $2.5 billion (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Novartis Ag | 107,124,802.25 Bn | 107,124,802.25 Bn | - | - |
| 2 | Eli Lilly | 969.00 Bn | 963.72 Bn | 16.22 Bn | 3.51 Bn |
| 3 | Johnson & Johnson | 539.46 Bn | 517.41 Bn | 15.96 Bn | 3.53 Bn |
| 4 | AbbVie | 376.92 Bn | 367.57 Bn | 10.78 Bn | 2.47 Bn |
| 5 | Merck | 285.00 Bn | 279.35 Bn | 12.09 Bn | 12.59 Bn |
| 6 | Amgen | 177.58 Bn | 165.55 Bn | 5.87 Bn | 1.72 Bn |
| 7 | Gilead Sciences | 163.22 Bn | 155.50 Bn | 5.52 Bn | 1.37 Bn |
| 8 | Pfizer | 145.86 Bn | 133.09 Bn | -1.21 Bn | 2.49 Bn |
| 9 | Bristol Myers Squibb | 111.90 Bn | 101.44 Bn | 8.07 Bn | 2.65 Bn |
| 10 | Gsk | 88.34 Bn | 83.66 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.65 Bn |
| Dec 31, 2025 | 2.59 Bn |
| Sep 30, 2025 | 2.53 Bn |
| Jun 30, 2025 | 2.58 Bn |
| Mar 31, 2025 | 2.26 Bn |
| Dec 31, 2024 | 3.19 Bn |
| Sep 30, 2024 | 2.37 Bn |
| Jun 30, 2024 | 2.90 Bn |
| Mar 31, 2024 | 2.70 Bn |
| Dec 31, 2023 | 2.48 Bn |
| Sep 30, 2023 | 2.24 Bn |
| Jun 30, 2023 | 2.26 Bn |
| Mar 31, 2023 | 2.32 Bn |
| Dec 31, 2022 | 2.51 Bn |
| Sep 30, 2022 | 2.42 Bn |
| Jun 30, 2022 | 2.32 Bn |
| Mar 31, 2022 | 2.26 Bn |
| Dec 31, 2021 | 2.52 Bn |
| Sep 30, 2021 | 2.98 Bn |
| Jun 30, 2021 | 2.48 Bn |
| Mar 31, 2021 | 2.22 Bn |
| Dec 31, 2020 | 2.66 Bn |
| Sep 30, 2020 | 2.50 Bn |
| Jun 30, 2020 | 2.52 Bn |
| Mar 31, 2020 | 2.37 Bn |
| Dec 31, 2019 | 2.10 Bn |
| Sep 30, 2019 | 1.38 Bn |
| Jun 30, 2019 | 1.33 Bn |
| Mar 31, 2019 | 1.35 Bn |
| Dec 31, 2018 | 1.37 Bn |
| Sep 30, 2018 | 1.28 Bn |
| Jun 30, 2018 | 2.44 Bn |
| Mar 31, 2018 | 1.25 Bn |
| Dec 31, 2017 | 1.93 Bn |
| Sep 30, 2017 | 1.56 Bn |
| Jun 30, 2017 | 1.68 Bn |
| Mar 31, 2017 | 1.30 Bn |
| Dec 31, 2016 | 1.47 Bn |
| Sep 30, 2016 | 1.14 Bn |
| Jun 30, 2016 | 1.27 Bn |
| Mar 31, 2016 | 1.14 Bn |
| Dec 31, 2015 | 1.92 Bn |
| Sep 30, 2015 | 1.13 Bn |
| Jun 30, 2015 | 1.86 Bn |
| Mar 31, 2015 | 1.02 Bn |
| Dec 31, 2014 | 1.19 Bn |
| Sep 30, 2014 | 983.00 Mn |
| Jun 30, 2014 | 1.42 Bn |
| Mar 31, 2014 | 946.00 Mn |
| Dec 31, 2013 | 957.00 Mn |
| Sep 30, 2013 | 893.00 Mn |
| Jun 30, 2013 | 951.00 Mn |
| Mar 31, 2013 | 930.00 Mn |
| Dec 31, 2012 | 1.08 Bn |
| Sep 30, 2012 | 951.00 Mn |
| Jun 30, 2012 | 962.00 Mn |
| Mar 31, 2012 | 909.00 Mn |
| Dec 31, 2011 | 1.01 Bn |
| Sep 30, 2011 | 973.00 Mn |
| Jun 30, 2011 | 923.00 Mn |
| Mar 31, 2011 | 935.00 Mn |
| Dec 31, 2010 | 1.01 Bn |
| Sep 30, 2010 | 824.00 Mn |
| Jun 30, 2010 | 822.00 Mn |
| Mar 31, 2010 | 910.00 Mn |
| Dec 31, 2009 | 1.11 Bn |
| Sep 30, 2009 | 820.00 Mn |
| Jun 30, 2009 | 811.00 Mn |
| Mar 31, 2009 | 908.00 Mn |